Cancer Reports Associated with 2018 Recalls of Angiotensin Receptor Blockers

2021 
In July 2018, several lots of the angiotensin receptor blocker (ARB) valsartan were recalled worldwide because the potential carcinogen
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []